Insulet Corporation (PODD)

NASDAQ: PODD · IEX Real-Time Price · USD
194.93
-4.07 (-2.05%)
Jan 27, 2022 3:59 PM EST - Market open

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager.

The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East.

Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
Insulet Logo
CountryUnited States
Founded2000
IPO DateMay 15, 2007
IndustryHealth Care Equipment & Supplies
SectorHealth Care
Employees1,900
CEOShacey Petrovic

Contact Details

Address:
100 Nagog Park
Acton, Massachusetts 01720-3440
United States
Phone978 600 7000
Websitemyomnipod.com

Stock Details

Ticker SymbolPODD
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001145197

Key Executives

NamePosition
Shacey PetrovicPresident, Chief Executive Officer and Director
Wayde D. McMillanExecutive Vice President,Chief Financial Officer and Treasurer
Charles AlpucheExecutive Vice President and Chief Operating Officer
Dan ManeaSenior Vice President and Chief Human Resources Officer
Bret ChristensenExecutive Vice President and Chief Commercial Officer
Lauren BuddenVice President, Chief Accounting Officer and Controller
Deborah R. Gordon CPAVice President of Investor Relations
Michael SpearsSenior Vice President of Regulatory Affairs and Compliance
John Wodick KapplesSenior Vice President, Secretary and General Counsel
Angela Geryak WiczekSenior Director of Corporate Communications

Latest SEC Filings

DateTypeTitle
Jan 7, 20224Statement of changes in beneficial ownership of securities
Jan 5, 20224Statement of changes in beneficial ownership of securities
Jan 4, 20224Statement of changes in beneficial ownership of securities
Dec 17, 20214Statement of changes in beneficial ownership of securities
Dec 8, 20214Statement of changes in beneficial ownership of securities
Nov 12, 20214Statement of changes in beneficial ownership of securities
Nov 4, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 4, 20218-KCurrent report
Oct 18, 20214Statement of changes in beneficial ownership of securities
Oct 18, 20213Initial statement of beneficial ownership of securities
View All SEC Filings